FridayAug 17, 2018 1:15 pm

Preparation, Opportunity Strengthen First Cobalt Corp.’s (TSX.V: FCC) (OTCQX: FTSSF) Outlook as Potential Supplier of In-Demand Metal

Tech-industry demand for cobalt predicted to drive doubling of need for battery element during next decade First Cobalt exploring quick-to-market potential of Idaho project while assessing fire-up capacity of continent’s only permitted cobalt refinery Company also has 50 past-producing mines in Canada’s famed Cobalt Camp Cobalt’s rising star in the metal commodities market and the potential fast-track-to-production resources of First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) (ASX: FCC) appear to be a rock solid marriage of preparation and opportunity within the exploration industry. Cobalt’s clout derives from its current position as a limited supply element vital to the low-heat, high-stability…

Continue Reading

FridayAug 17, 2018 12:40 pm

Sharing Services, Inc. (SHRV) Revenues Rapidly Increase as Multi-Level Marketing Model Thrives on New Wellness Products

Elevate product line boosts fourth quarter sales in excess of $7 million Potential for rapid further growth in market worth $12 billion Application of successful multi-level marketing model to other business units The “Elevate” product line distributed by Sharing Services, Inc. (OTC: SHRV) turns out to have been aptly named, as scrutiny of the company’s Annual Report (10-K), recently filed with the SEC, will reveal (http://ibn.fm/v7yJx). Consolidated net sales for the first fiscal year, consisting primarily of Elevate products, totaled $8.4 million and included $7.4 million in the fourth quarter ended April 30, 2018. The company has high hopes for…

Continue Reading

FridayAug 17, 2018 12:03 pm

NUGL Inc. (NUGL) Cannabis Brand Locator, Profile App Set to Sweep North America

Comprehensive, flexible web app technology means superior service that meets the needs of expanding cannabis community and industry Powerful web app based engine offers unique search functionality, profile building and networking capabilities for cannabis cultivators, brands, dispensaries and all associated service-related industries U.S. legal cannabis market projected to reach more than $23 billion in consumer spending by 2022 NUGL app gives consumers easy-to-locate info on all things cannabis, with unbiased reviews connecting users to their favorite brands, locations Serving international markets with no geographic limitations thanks to innovative, first-to-market technology NUGL Inc. (OTC: NUGL), the cannabis industry’s new standard of…

Continue Reading

FridayAug 17, 2018 11:33 am

CytoDyn Inc. (CYDY) is “One to Watch”

PRO 140 is a leading monoclonal antibody/viral-entry inhibitor therapy under development for two different Human Immunodeficiency Virus (HIV) indications and is also being pursued for multiple opportunities in other immunologic indications such as autoimmune disease, chronic inflammation, certain cancers, and transplant rejection During 2017, 1.8 million people became newly infected with HIV, bringing the global total to 36.9 million people living with HIV (World Health Organization) Market potential for PRO 140 used as an anti-viral agent in combination with HAART is $1.2 billion; as a monotherapy maintenance/single-drug therapy the market is estimated at $3.8 billion CytoDyn Inc. (OTCQB: CYDY) is…

Continue Reading

ThursdayAug 16, 2018 1:44 pm

PreveCeutical Medical Inc.’s (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Medicinal Cannabis Division Targets Treatment Option for Anxiety Disorders

Anxiety is implicated in several chronic physical illnesses including heart disease, respiratory disorders and gastrointestinal conditions Scientific evidence in several studies shows that CBD exhibits anti-inflammatory and anti-anxiety properties Newly created medicinal cannabis division will focus on development of cannabinoids as preventative treatment for anxiety disorders Use of PreveCeutical’s proprietary Sol-gel nasal delivery platform for cannabinoid therapy promises ease of use, sustained release, better efficacy Preventative medicine industry represents a $3.8 trillion market Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is tackling a topic that many people hesitate to bring up – anxiety disorders, including…

Continue Reading

ThursdayAug 16, 2018 1:19 pm

First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) Optimistic about Iron Creek Expansion as EV Market Continues Exponential Growth

Company accelerates drilling activities at Idaho site with the installation of two new drill rigs Drilling from underground successfully extending mineralization of Waite Zone U.S. needs to add 14 million plug-in electric vehicles and more than 300,000 public charging outlets by end of 2025 to meet Paris Agreement goals The United States needs to ramp up production of electric vehicles considerably in order to meet Paris Agreement target goals by 2025. This market growth is expected to translate into an overall higher demand for cobalt, one of the key components of the lithium-ion batteries that power electric vehicles, making clean,…

Continue Reading

ThursdayAug 16, 2018 12:58 pm

Zenergy Brands, Inc. (ZNGY) Leading the Way for Companies Wishing to Invest in Energy Efficiency

30 percent of energy used in commercial buildings is wasted, an issue that most businesses wish to address Cost of energy-efficient renovation is daunting for most companies Zenergy’s Zero Cost Program makes it possible for businesses of all sizes to reduce utility consumption by 20 to 60 percent According to the U.S. Environmental Protection Agency, 30 percent of the energy used in commercial buildings is wasted. The commercial building sector is the largest user of energy and emitter of greenhouse gasses in the U.S., and the U.S. is currently the largest global user of energy. Sustainable investments toward energy efficiency…

Continue Reading

ThursdayAug 16, 2018 11:37 am

Pressure BioSciences Inc. (PBIO) Reports Significant Financial and Operational Achievements during Highly Successful Q2

Pressure BioSciences Inc. announced strong financial results for the second quarter of 2018, demonstrating the company’s growth and stability Products and services revenue increased for the tenth consecutive quarter (YoY) while registering growth of 29 percent compared to Q2 2017 Company sets all-time first half fiscal year total revenue record A partnership with Ohio State University will enable the company to seek expansion in new industries like food, beverages, pharmaceuticals and cosmetics Pressure BioSciences Inc. (OTCQB: PBIO) recently announced its financial results for the second quarter of 2018, highlighting one of the most successful periods in the history of the…

Continue Reading

ThursdayAug 16, 2018 11:27 am

Independent Researchers at SeeThruEquity Take Note of Advances at Payment Solutions Company Net Element, Inc. (NASDAQ: NETE)

Rise in transaction volume, product enhancements and asset acquisition show Net Element’s ongoing growth strategy SeeThruEquity labels Net Element an ‘intriguing’ high-risk, high-reward growth company with stable share price target Since 2014, Net Element’s revenues from payment processing services have nearly tripled A series of optimistic developments for payment tech processor Net Element, Inc. (NASDAQ: NETE) has led independent equity research firm SeeThruEquity to issue an update of its coverage on the company (http://ibn.fm/7NBjg). The research firm is taking note of Net Element’s forecast for an increase in gross profits based on its acquisition of services assets from partner Universal Payment…

Continue Reading

WednesdayAug 15, 2018 12:41 pm

CytoDyn Inc. (CYDY) Sees Promising HIV Treatment Trial Results, Gets Go-Ahead to Raise Dosage

Response rate to PRO 140 rose from 40 percent at 350mg dose to 70 percent at 525mg Institutional Review Board (IRB) allows trials of viral-entry inhibitor to continue at 700mg dose PRO 140 is an FDA fast-track candidate Following clinical trial results showing that its new anti-HIV treatment is more effective at higher dosages, biotechnology company CytoDyn Inc. (OTCQB: CYDY) is set to give trial participants an increased weekly dose of PRO 140 (http://ibn.fm/oyLRe). The latest round of trial results showed that the response rate among trial participants treated with the viral-entry inhibitor rose from 40 percent at a 350mg weekly…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered